The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells

Influenza and other Respiratory Viruses

Volumn 11, Issue 3, 2017, Pages 263-274

  Lin, Yipu ^a   Wharton, Stephen A ^a   Whittaker, Lynne ^a   Dai, Mian ^a   Ermetal, Burcu ^a   Lo, Janice ^b   Pontoriero, Andrea ^c   Baumeister, Elsa ^c   Daniels, Rodney S ^a   McCauley, John W ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b DEPARTMENT OF HEALTH   (China)

^c INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

antigenicity; influenza; MDCK cells; MDCK SIAT1 cells; receptor binding

Indexed keywords

OSELTAMIVIR; SIALIDASE; INFLUENZA VIRUS HEMAGGLUTININ;

ANTIGENICITY; ARTICLE; ENZYME ACTIVITY; FLUORESCENCE; GENETIC POLYMORPHISM; HEMAGGLUTINATION TEST; INFLUENZA A (H3N2); MDCK CELL LINE; NEXT GENERATION SEQUENCING; NONHUMAN; PLAQUE FORMING CELL ASSAY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS NEUTRALIZATION; AGGLUTINATION TEST; AMINO ACID SUBSTITUTION; ANIMAL; BLOOD CELL; DOG; GENETICS; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H3N2); ISOLATION AND PURIFICATION; TURKEY (BIRD); VIROLOGY; VIRUS CULTURE;

AGGLUTINATION TESTS; AMINO ACID SUBSTITUTION; ANIMALS; BLOOD CELLS; DOGS; GUINEA PIGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; SERIAL PASSAGE; TURKEYS;

EID: 85014266499     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12447     Document Type: Article

References (17)

1. Lin YP, Xiong X, Wharton SA, et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci USA. 2012;109:21474-21479.
2. Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology. 2001;289:74-85.
3. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology. 2000;278:587-596.
4. Oh DY, Barr IG, Mosse JA, Laurie KL. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol. 2008;46:2189-2194.
5. Asaoka N, Tanaka Y, Sakai T, Fujii Y, Ohuchi R, Ohuchi M. Low growth ability of recent influenza clinical isolates in MDCK cells is due to their low receptor binding affinities. Microbes Infect. 2006;8:511-519.
6. Lin YP, Gregory V, Collins P, et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol. 2010;84:6769-6781.
7. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003;77:8418-8425.
8. WHO. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec. 2014;89:93-104.
9. Skowronski DM, Sabaiduc S, Chambers C, et al. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Euro Surveillance. 2016;21:30112-30119.
10. WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. http://www.who.int/influenza/gisrs_laboratory/en/2011.
11. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem. 1979;94:287-296.
12. Zhou B, Donnelly ME, Scholes DT, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol. 2009;83:10309-10313.
13. Sullivan K, Kloess J, Qian C, et al. High throughput virus plaque quantitation using a flatbed scanner. J Virol Methods. 2012;179:81-89.
14. Lin Y, Gu Y, Wharton SA, et al. Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses. Influenza Other Respir Viruses. 2015;9:331-340.
15. WHO. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season. Wkly Epidemiol Rec. 2015;90:97-108.
16. WHO. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season. Wkly Epidemiol Rec. 2015;90:545-560.
17. Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Rep. 2015;12:1-6.